Journals / Haydarpaşa Numune Medical Journal / 2021 / Cilt: 61 - Sayı: 4

Investigation of the Relationship Between Apelin Genetic Variants and COPD Formation

Pages
397–400
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Discussion and Conclusion: As the first study in the literature examining the relationship between polymorphisms in the APLN and COPD in the Turkish population, various variations in the APLN were found to be associated with COPD in the Turkish population.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Chronic obstructive pulmonary disease (COPD) is a common, preventable, and treatable disease characterized by chronic inflammatory response in the airways and lungs, usually characterized by progressive, persistent airflow limitation.
📊
Key Findings & Data:Methods: This study was a case-control study, and a total of 341 people aged 40-80 years were included in the study (224 COPD and 117 healthy controls).
💡
Conclusion & Impact:Discussion and Conclusion: As the first study in the literature examining the relationship between polymorphisms in the APLN and COPD in the Turkish population, various variations in the APLN were found to be associated with COPD in the Turkish population.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: Chronic obstructive pulmonary disease (COPD) is a common, preventable, and treatable disease characterized by chronic inflammatory response in the airways and lungs, usually characterized by progressive, persistent airflow limitation. Apelin is a newly discovered peptide with inotropic and vasodilatory properties and is an endogenous ligand of the APJ receptor. The aim of this study is to examine the possible association of variations in the apelin gene (APLN) with COPD in the Turkish population. Methods: This study was a case-control study, and a total of 341 people aged 40-80 years were included in the study (224 COPD and 117 healthy controls). Genotyping of 2 single nucleotide polymorphisms (SNPs) (rs3115758 and rs3115759) in the APLN was performed by real-time polymerase chain reaction (PCR) method. Genotype and allele frequencies between COPD patients and healthy individuals were compared with Student's t test. Results: The TT and AA risk genotypes of the rs3115758 and rs3115759 variants in the APLN were found to be associated with a significantly increased risk of COPD at the same rate. Heterozygous and homozygous mutant genotypes (GT, TT, GA, and AA, respectively) of rs3115758 and rs3115759 variations of the APLN were detected at a significantly higher rate, in the same proportion of patients. In the multiple regression analysis, it was determined that the TT genotype of rs3115758 increased the development of COPD by 0.59 times, independent of other COPD risk factors. Discussion and Conclusion: As the first study in the literature examining the relationship between polymorphisms in the APLN and COPD in the Turkish population, various variations in the APLN were found to be associated with COPD in the Turkish population.

🔖

Cite This Article

COŞKUNPINAR, E., YILDIZ, B. P., EKMEKÇİ, C. G., MELEKOĞLU, A. (2022). Investigation of the Relationship Between Apelin Genetic Variants and COPD Formation. Haydarpaşa Numune Medical Journal, Cilt: 61 - Sayı: 4, 397–400. https://ajindex.com/articles/535892

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Gupta N, Agrawal S, Chakrabarti S, Ish P. COPD 2020 Guidelines - what is new and why? Adv Respir Med 2020;88:38–40
  2. Chwalba A, Machura E, Ziora K, Ziora D. The role of adipokines in the pathogenesis and course of selected respiratory diseases. Endokrynol Pol 2019;70:504–10
  3. Yan J, Wang A, Cao J, Chen L. Apelin/APJ system: an emerging therapeutic target for respiratory diseases. Cell Mol Life Sci 2020;77:2919-30
  4. Hosoya M, Kawamata Y, Fukusumi S, Fujii R, Habata Y, Hinuma S, et al. Molecular and functional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand apelin. J Biol Chem 2000;275:21061–7
  5. Lv SY, Yang YJ, Chen Q. Regulation of feeding behavior, gastrointestinal function and fluid homeostasis by apelin. Peptides 2013;44:87–92
  6. Pakizeh E, Çoşkunpınar E, Oltulu YM, Çakmak HA, İkitimur B, Işık Sağlam ZM, et al. The assessment of the relationship between variations in the apelin gene and coronary artery disease in Turkish population. Anatol J Cardiol. 2015;15:716–21
  7. Esteban-Martínez RL, Pérez-Razo JC, Vargas-Alarcón G, Martínez-Rodríguez N, Cano-Martínez LJ, López-Hernández LB, et al. Polymorphisms of APLN-APLNR system are associated with essential hypertension in Mexican-Mestizo individuals. Exp Mol Pathol 2016;101:105–9
  8. Guo R, Rogers O, Nair S. Targeting apelinergic system in cardiometabolic disease. Curr Drug Targets 2017;18:1785–91
  9. Cavallaro G, Filippi L, Bagnoli P, La Marca G, Cristofori G, Raffaeli G, et al. The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge. Acta Ophthalmol 2014;92:2–20
  10. Suriyaprom K, Pheungruang B, Tungtrongchitr R, Sroijit OY. Relationships of apelin concentration and APLN T-1860C polymorphism with obesity in Thai children. BMC Pediatr 2020;20:455
  11. Lin WY, Lakkakula BV, Yu ML, Juo SH. Apelin gene polymorphism influences apelin expression and obesity phenotypes in Chinese women. Am J Clin Nutr 2011;94:921–8
  12. Mesallamy HO. Genotype screening of APLN rs3115757 variant in Egyptian women population reveals an association with obesity and insulin resistance. Diabetes Res Clin Pract 2015;109:40–7
  13. Kotanidou EP, Kalinderi K, Kyrgios I, Efraimidou S, Fidani L, Papadopoulou- Alataki E, et al. Apelin and G212A apelin receptor gene polymorphism in obese and diabese youth. Pediatr Obes 2015;10:213–9
  14. Hofmann AD, Friedmacher F, Takahashi H, Hunziker M, Gosemann JH, Puri P. Decreased apelin and apelin-receptor ex